TrialFrontiers in immunology2023

Homologous versus Heterologous prime-boost COVID-19 Vaccination in autologous hematopoietic stem cell transplantation recipients: a blinded randomized controlled trial.

Leyla Sharifi Aliabadi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.